Site Search
Results
-
NTP Monograph: Systematic Review of Occupational Exposure to...
... Antibiotics + + + + Hormone Therapies + + + + Mitotic Function Inhibitors ... (e.g., doxorubicin), hormone therapies (e.g., tamoxifen), mitotic function ...
Size: 6.2MB https://ntp.niehs.nih.gov/go/mgraph05 -
TOX-5: Cobalt Sulfate Heptahydrate CASRN 10026-24-1
... This practice has largely stopped because of associ- ated toxicity (gastrointestinal upset, goiter, car- diomyopathies) and the development of less haz- ardous therapies. It has ...
Size: 2.9MB https://ntp.niehs.nih.gov/go/tox005 -
Workshop Report: Alternative Methods to Replace Animal Use for...
... Cellular, Tissue Ph.D., M.D. and Gene Therapies, U.S. Food and Drug Administration ... efforts directed towards antibody-based therapies 10 Workshop on Alternative Methods for ...
Size: 10.1MB https://ntp.niehs.nih.gov/iccvam/docs/biologics-docs/bontwkshprept.pdf -
RoC Background Document for Hepatitis C Virus; June 11, 2003
... Currently, HCV is treated by interferon-related therapies, and no vaccine is available. ... vaccines 2.4.1 Treatment In a review of therapies for HCV infection, McHutchison et al. ...
Size: 2.1MB https://ntp.niehs.nih.gov/sites/default/files/ntp/newhomeroc/roc11/hcv_rg2public_508.pdf -
RoC Background Document on Human Papillomaviruses: Genital-Mucosal...
... topical applications, interferon-related therapies, laser methods, and surgical excision. ... warts include topical applications, surgical excision, and interferon-related therapies. ...
Size: 2.9MB https://ntp.niehs.nih.gov/sites/default/files/ntp/newhomeroc/roc11/hpv_rg2_public_508.pdf -
OHAT Evaluation: Protocol for a Systematic Review to Evaluate...
... synthetic hormones (e.g., tamoxifen), monoclonal antibodies and other targeted therapies (e.g., imatinib) Comparator A comparison population exposed to lower levels (or no ...
Size: 1018KB https://ntp.niehs.nih.gov/sites/default/files/ntp/ohat/aheaoecca/protocol201510_508.pdf -
Protocol: Occupational Exposure to Cancer Chemotherapy Agents...
... synthetic hormones (e.g., tamoxifen), monoclonal antibodies and other targeted therapies (e.g., imatinib) Comparator A comparison population exposed to lower levels (or no ...
Size: 883KB https://ntp.niehs.nih.gov/sites/default/files/ntp/ohat/aheaoecca/protocol201812_508.pdf -
Minutes: BSC; Sept. 17, 2002
... Bucher, NIEHS, discussed some of the focused areas of toxicology research that the NTP is working on, including 1. DNA-based therapies -nominated by FDA for study because of ...
Size: 762KB https://ntp.niehs.nih.gov/sites/default/files/ntp/about_ntp/bsc/archives/2002/september/20020917bscsummmins_508.pdf -
Draft RoC Monograph Epstein-Barr virus (EBV): RoC Peer Review...
... such as anti-rejection therapies or congenital immunodeficiency (Carbone et al. 2008). ... EBV-related non-Hodgkin lymphomas have been linked to immunosuppression therapies related ...
Size: 1.5MB https://ntp.niehs.nih.gov/sites/default/files/ntp/about_ntp/monopeerrvw/2015/december/ebv_peer_draft_monograph.pdf -
Draft RoC Monograph Human immunodeficiency virus type 1 (HIV...
... are called highly active antiretroviral therapies (HAART) or cART (combination ... The availability of antiretroviral therapies, particularly the new generation of drugs, ...
Size: 2.1MB https://ntp.niehs.nih.gov/sites/default/files/ntp/about_ntp/monopeerrvw/2015/december/hiv_peer_draft_monograph.pdf
to Top